Skip to main content
Q-Linea logo

Q-Linea — Investor Relations & Filings

Ticker · QLINEA ISIN · SE0011527845 LEI · 549300BXVB4XRM8WSC73 ST Manufacturing
Open in API
Filings indexed 322 across all filing types
Latest filing 2022-05-24 AGM Information
Country SE Sweden
Listing ST QLINEA

About Q-Linea

https://www.qlinea.com/

Q-Linea is an infection diagnostics company that develops and manufactures solutions for infectious diseases, with a primary focus on sepsis. The company's core product is the ASTar instrument, a fully automated, benchtop system that provides rapid phenotypic antimicrobial susceptibility testing (AST) directly from positive blood cultures. The ASTar system is designed to significantly reduce the time to result compared to traditional diagnostic methods, which can take up to 48 hours. By delivering faster results, the technology enables clinicians to make earlier, more informed decisions on appropriate antibiotic treatments for critically ill patients. This capability aims to improve patient outcomes, support antibiotic stewardship, and help combat the development of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)
AGM Information Classification · 99% confidence The document is explicitly titled "BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)" and details the resolutions adopted during the meeting, such as the adoption of financial statements, allocation of results (no dividend), discharge from liability, election of the board and auditor, and authorization for share issues. These are all core activities of an Annual General Meeting (AGM). Although it mentions the adoption of the income statement and balance sheet, the primary context and structure revolve around the meeting's proceedings and decisions, making AGM-R the most appropriate classification.
2022-05-24 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period 1 January to 31 March 2022. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and detailed management commentary on business performance, clinical studies, and regulatory progress. It is not an announcement of a report, but the report itself, containing substantive financial data. Q1 2022
2022-05-05 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report 1 JANUARY–31 MARCH 2022' and contains detailed financial statements, including net sales, operating results, earnings per share, cash flow, and balance sheet data for the specified quarter. It provides a comprehensive analysis of business performance, significant events, and financial position, which aligns perfectly with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-05 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 95% confidence The document is a 'Bokslutskommuniké' (Year-end report) for the period 1 January – 31 December 2021. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and detailed management commentary on business performance, operational milestones, and future outlook. As it covers a full fiscal year and provides substantive financial data, it qualifies as an annual financial report. In the context of the provided categories, this aligns with the definition of an Interim/Quarterly Report (IR) or Annual Report (10-K). Given it is a year-end report (Bokslutskommuniké) which functions as the final quarterly report of the year, it is classified as an Interim/Quarterly Report (IR) as it provides the full-year financial performance. FY 2021
2022-02-17 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Year-end report' covering the period 1 January – 31 December 2021, including detailed financial results for the fourth quarter and the full year. It contains comprehensive financial statements, management commentary, and operational updates. It is not an announcement of a report (RPA) or a simple earnings release (ER), as it provides substantive financial analysis and data, fitting the definition of an Interim/Quarterly Report (IR) for the final period of the fiscal year. FY 2021
2022-02-17 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period 1 January to 30 September 2021. It contains comprehensive financial statements, including income statements, cash flow analysis, and balance sheet data, along with management's commentary on business performance and future outlook. It is not a mere announcement or certification, but the full interim financial report itself. 9M 2021
2021-11-04 Swedish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.